Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
Clinical trial NCT00470704 · COMPLETED
Trial details
- NCT number
- NCT00470704
- Sponsor
- Nancy Lin, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-14
- Primary completion
- 2013-11-30
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.